Patent classifications
A61K36/79
COMPOSITIONS FOR THE TREATMENT OF AGE RELATED DISORDERS
The invention is directed to compositions for the prophylaxis, treatment and recovery of age related disorders. Compositions comprising a combination of parts of plants or plant extracts belonging to Crassulaceae, Araliaceae and Schisandraceae for the prophylaxis and treatment of age related disorders.
COMPOSITIONS FOR THE TREATMENT OF OVERTRAINING SYNDROME
The invention is directed to compositions for the prophylaxis, treatment and recovery of overtraining syndrome. Compositions comprising a combination of parts of plants or plant extracts belonging to Crassulaceae, Araliaceae and Schisandraceae for the prophylaxis and treatment of overtraining syndrome. In a preferred embodiment the composition further comprises parts of plants or plant extracts of Asteraceae and or pantothenic acid or salts thereof.
COMPOSITIONS FOR THE TREATMENT OF OVERTRAINING SYNDROME
The invention is directed to compositions for the prophylaxis, treatment and recovery of overtraining syndrome. Compositions comprising a combination of parts of plants or plant extracts belonging to Crassulaceae, Araliaceae and Schisandraceae for the prophylaxis and treatment of overtraining syndrome. In a preferred embodiment the composition further comprises parts of plants or plant extracts of Asteraceae and or pantothenic acid or salts thereof.
COMPOSITIONS FOR THE TREATMENT OF OVERTRAINING SYNDROME
The invention is directed to compositions for the prophylaxis, treatment and recovery of overtraining syndrome. Compositions comprising a combination of parts of plants or plant extracts belonging to Crassulaceae, Araliaceae and Schisandraceae for the prophylaxis and treatment of overtraining syndrome. In a preferred embodiment the composition further comprises parts of plants or plant extracts of Asteraceae and or pantothenic acid or salts thereof.
HERBAL COMPOSITION FOR REDUCING URIC ACID AND THE USE IN REDUCING URIC ACID, BODY FAT, AND BLOOD GLUCOSE THEREOF
Provided herein is a pharmaceutical composition comprising 1-2 part by weight of Schisandra chinensis powder and 5-10 part by weight of extract of Psidium guajava L. The composition can be used in the treatment of reducing blood uric acid, protecting pancreatic beta cell, and reducing body fat.
HERBAL COMPOSITION FOR REDUCING URIC ACID AND THE USE IN REDUCING URIC ACID, BODY FAT, AND BLOOD GLUCOSE THEREOF
Provided herein is a pharmaceutical composition comprising 1-2 part by weight of Schisandra chinensis powder and 5-10 part by weight of extract of Psidium guajava L. The composition can be used in the treatment of reducing blood uric acid, protecting pancreatic beta cell, and reducing body fat.
HERBAL COMPOSITION FOR REDUCING URIC ACID AND THE USE IN REDUCING URIC ACID, BODY FAT, AND BLOOD GLUCOSE THEREOF
Provided herein is a pharmaceutical composition comprising 1-2 part by weight of Schisandra chinensis powder and 5-10 part by weight of extract of Psidium guajava L. The composition can be used in the treatment of reducing blood uric acid, protecting pancreatic beta cell, and reducing body fat.
USE OF GINSENG ALCOHOL EXTRACT IN SLEEP-PROMOTING HEALTH CARE PRODUCTS OR FOODS
The present disclosure belongs to the technical field of health care products or foods and provides the use of a ginseng alcohol extract in sleep-promoting health care products or foods. Through analysis utilizing DAM2 drosophila behavior monitoring system, it is found that the ginseng alcohol extract can increase total sleep duration of normal and sleep deprived drosophilae, and relieve sleep rhythm disorder caused by sleep deprivation. Through a climbing experiment, it is found that the ginseng alcohol extract can improve the climbing ability of normal and sleep deprived drosophilae. The ginseng alcohol extract, on the one hand, improves the quality of sleep to protect the steady state of sleep rhythm, and on the other hand, increases the motive ability after sleep. The ginseng alcohol extract of the present disclosure is intended to be used to sleep-promoting health care products or healthy foods and improve the quality of sleep.
USE OF GINSENG ALCOHOL EXTRACT IN SLEEP-PROMOTING HEALTH CARE PRODUCTS OR FOODS
The present disclosure belongs to the technical field of health care products or foods and provides the use of a ginseng alcohol extract in sleep-promoting health care products or foods. Through analysis utilizing DAM2 drosophila behavior monitoring system, it is found that the ginseng alcohol extract can increase total sleep duration of normal and sleep deprived drosophilae, and relieve sleep rhythm disorder caused by sleep deprivation. Through a climbing experiment, it is found that the ginseng alcohol extract can improve the climbing ability of normal and sleep deprived drosophilae. The ginseng alcohol extract, on the one hand, improves the quality of sleep to protect the steady state of sleep rhythm, and on the other hand, increases the motive ability after sleep. The ginseng alcohol extract of the present disclosure is intended to be used to sleep-promoting health care products or healthy foods and improve the quality of sleep.
CENTRAL NERVOUS SYSTEM HEALTH SUPPLEMENT
An orally administered composition positively mitigates the progression of central nervous system diseases such as Alzheimer's, Parkinson's and Multiple Sclerosis. The composition consists of a lipid based blood brain barrier transport medium (Base Transport Sub-Formula) to which other elements (Functional Targeting Compound) may be integrated to mediate specific chemo-neurological dysfunction. It may be administered through the mouth as droplets a spray medium or a chewable tablet.